ITCI
Price
$70.34
Change
-$2.39 (-3.29%)
Updated
May 2, 6:59 PM EST
4 days until earnings call
SUPN
Price
$30.27
Change
+$0.19 (+0.63%)
Updated
May 2, 6:59 PM EST
5 days until earnings call
Ad is loading...

Compare trend and price ITCI vs SUPN

Header iconITCI vs SUPN Comparison
Open Charts ITCI vs SUPNBanner chart's image
Intra-Cellular Therapies
Price$70.34
Change-$2.39 (-3.29%)
Volume$713.49K
CapitalizationN/A
Supernus Pharmaceuticals
Price$30.27
Change+$0.19 (+0.63%)
Volume$151.59K
CapitalizationN/A
View a ticker or compare two or three
ITCI vs SUPN Comparison Chart

Loading...

ITCIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SUPNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ITCI vs. SUPN commentary
May 03, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITCI is a Hold and SUPN is a StrongBuy.

COMPARISON
Comparison
May 03, 2024
Stock price -- (ITCI: $70.34 vs. SUPN: $30.27)
Brand notoriety: ITCI: Notable vs. SUPN: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ITCI: 127% vs. SUPN: 75%
Market capitalization -- ITCI: $6.7B vs. SUPN: $1.84B
ITCI [@Pharmaceuticals: Other] is valued at $6.7B. SUPN’s [@Pharmaceuticals: Other] market capitalization is $1.84B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ITCI’s FA Score shows that 1 FA rating(s) are green whileSUPN’s FA Score has 1 green FA rating(s).

  • ITCI’s FA Score: 1 green, 4 red.
  • SUPN’s FA Score: 1 green, 4 red.
According to our system of comparison, ITCI is a better buy in the long-term than SUPN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ITCI’s TA Score shows that 5 TA indicator(s) are bullish while SUPN’s TA Score has 6 bullish TA indicator(s).

  • ITCI’s TA Score: 5 bullish, 5 bearish.
  • SUPN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SUPN is a better buy in the short-term than ITCI.

Price Growth

ITCI (@Pharmaceuticals: Other) experienced а -2.48% price change this week, while SUPN (@Pharmaceuticals: Other) price change was +3.28% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.55%. For the same industry, the average monthly price growth was -2.99%, and the average quarterly price growth was +18944.31%.

Reported Earning Dates

ITCI is expected to report earnings on Aug 06, 2024.

SUPN is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (+3.55% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for ITCI with price predictions.
OPEN
A.I.dvisor published
a Summary for SUPN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ITCI($6.7B) has a higher market cap than SUPN($1.84B). SUPN YTD gains are higher at: 4.596 vs. ITCI (-1.787). SUPN has higher annual earnings (EBITDA): 90M vs. ITCI (-158.85M). ITCI has more cash in the bank: 498M vs. SUPN (255M). ITCI has less debt than SUPN: ITCI (16.9M) vs SUPN (41.5M). SUPN has higher revenues than ITCI: SUPN (608M) vs ITCI (462M).
ITCISUPNITCI / SUPN
Capitalization6.7B1.84B365%
EBITDA-158.85M90M-177%
Gain YTD-1.7874.596-39%
P/E RatioN/A1677.00-
Revenue462M608M76%
Total Cash498M255M195%
Total Debt16.9M41.5M41%
FUNDAMENTALS RATINGS
ITCI vs SUPN: Fundamental Ratings
ITCI
SUPN
OUTLOOK RATING
1..100
7214
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
9100
SMR RATING
1..100
9589
PRICE GROWTH RATING
1..100
4555
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ITCI's Valuation (74) in the Biotechnology industry is in the same range as SUPN (99) in the Pharmaceuticals Other industry. This means that ITCI’s stock grew similarly to SUPN’s over the last 12 months.

ITCI's Profit vs Risk Rating (9) in the Biotechnology industry is significantly better than the same rating for SUPN (100) in the Pharmaceuticals Other industry. This means that ITCI’s stock grew significantly faster than SUPN’s over the last 12 months.

SUPN's SMR Rating (89) in the Pharmaceuticals Other industry is in the same range as ITCI (95) in the Biotechnology industry. This means that SUPN’s stock grew similarly to ITCI’s over the last 12 months.

ITCI's Price Growth Rating (45) in the Biotechnology industry is in the same range as SUPN (55) in the Pharmaceuticals Other industry. This means that ITCI’s stock grew similarly to SUPN’s over the last 12 months.

SUPN's P/E Growth Rating (1) in the Pharmaceuticals Other industry is significantly better than the same rating for ITCI (100) in the Biotechnology industry. This means that SUPN’s stock grew significantly faster than ITCI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ITCISUPN
RSI
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 11 days ago
77%
Bullish Trend 4 days ago
70%
Declines
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 2 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
76%
View a ticker or compare two or three
Ad is loading...
ITCIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SUPNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OSTGX15.910.36
+2.32%
Osterweis Emerging Opportunity
LMARX58.710.88
+1.52%
ClearBridge Small Cap R
PBSIX13.450.16
+1.20%
Polen US Small Company Growth Instl
TWDAX16.410.19
+1.17%
Templeton World Adv
FRISX90.450.28
+0.31%
Franklin Rising Dividends R6

ITCI and

Correlation & Price change

A.I.dvisor tells us that ITCI and ACET have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ITCI and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITCI
1D Price
Change %
ITCI100%
-3.29%
ACET - ITCI
32%
Poorly correlated
-7.24%
NBIX - ITCI
32%
Poorly correlated
-2.24%
PCRX - ITCI
27%
Poorly correlated
+1.37%
ALKS - ITCI
27%
Poorly correlated
-0.62%
AVDL - ITCI
27%
Poorly correlated
-0.05%
More

SUPN and

Correlation & Price change

A.I.dvisor tells us that SUPN and SIGA have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SUPN and SIGA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SUPN
1D Price
Change %
SUPN100%
+0.63%
SIGA - SUPN
33%
Poorly correlated
+1.34%
AMPH - SUPN
31%
Poorly correlated
+1.38%
COLL - SUPN
30%
Poorly correlated
-0.71%
SNDL - SUPN
27%
Poorly correlated
+2.25%
ACET - SUPN
27%
Poorly correlated
-7.24%
More